'Triple negative' breast cancers linked to the young, minority

Mar 26, 2007

So-called “triple negative” breast cancers, tumors that do not contain any of three significant tumor markers, are aggressive, deadly cancers that affect young, poor minority women, according to a new study.

Published in the May 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that these tumors are more common among women who are African American and Hispanic, under 40 years old, and who have lower socioeconomic status (SES). The study found triple negative tumors are also associated with later diagnosis and shorter survival.

Tumor and tissue markers provide important information, including disease type and prognosis. Three important markers in breast cancer are estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and progesterone receptor (PR). In particular, these markers are useful in selecting appropriate adjuvant therapy and prognosis. Around 15 percent of breast cancers do not express any of these markers and are generally identified as basal-like subtypes. While these “triple negative” tumors are associated with poor prognosis and survival, hormone adjuvant therapy failure, and are often identified in African American women, little is understood about other associated demographic risk factors.

Katrina Bauer from the Public Health Institute in Sacramento, California and colleagues compared the demographic, clinical and survival characteristics of 6,370 women diagnosed with triple negative breast cancers with 44,704 women with other breast cancers.

The authors found that race and age, in particular, as well as socioeconomic status were risk factors for this type of breast cancer. Compared to Caucasians, African American women were at greatest risk followed by Hispanic women. Women under 40 years old were at greater risk than women over 60 years old. Women living in lower SES were also at higher risk compared to the highest SES.

Clinically, these tumors were more aggressive, diagnosed at more advanced stages. They were also associated with shorter survival, regardless of stage at diagnosis. African American women had the poorest five-year survival, with only 14 percent alive five years after diagnosis.

From these results, Ms. Bauer and co-authors conclude that “age less than 40 years, being non-Hispanic black and, to a lesser extent, being Hispanic, are clearly the most powerful risk factors for this poor prognosis subtype of breast cancer.”

Source: John Wiley & Sons, Inc.

Explore further: US OKs first-ever DNA alternative to Pap smear (Update 2)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

US OKs first-ever DNA alternative to Pap smear (Update 2)

13 hours ago

U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.

New breast cancer imaging method promising

18 hours ago

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Palliation is rarely a topic in studies on advanced cancer

19 hours ago

End-of-life aspects, the corresponding terminology, and the relevance of palliation in advanced cancer are often not considered in publications on randomized controlled trials (RCTs). This is the result of an analysis by ...

User comments : 0

More news stories

Google+ boss leaving the company

The executive credited with bringing the Google+ social network to life is leaving the Internet colossus after playing a key role there for nearly eight years.